25
Jul
Finance Minister Nirmala Sitharaman has announced duty exemption on three cancer drugs in the Union Budget 2024-25. These three drugs are Trastuzumab Deruxtecan, Osimertinib, and Durvalumab. Prior to the finance minister's announcement, imports of these three drugs were subject to 10 percent duty. Cancer patients will really benefit from the announcement of this tax exemption? How these cancer drugs help in cancer treatment- Trastuzumab Deruxtecan: It is a monoclonal antibody. It is used to treat breast and stomach cancers that have the HER-2 receptor. Currently, the price of this drug is around Rs 1.6 lakh per vial. Among women's cancers,…